Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
KUAISHOU-W
01024
5
JD HEALTH
06618
| (Q6)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q9)Sep 30, 2024 | (Q6)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q9)Sep 30, 2023 | (Q6)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | 0.13%56.64B | 3.62%22.89B | 1.21%115.11B | 12.33%89.29B | 2.64%56.57B | 2.07%22.09B | 11.53%113.73B | --79.49B | 2.42%55.11B | 24.90%21.64B |
| Operating income | 0.13%56.64B | 1.21%115.11B | 2.64%56.57B | 11.53%113.73B | 2.42%55.11B | |||||
| Cost of sales | -0.63%-48.11B | ---- | 0.14%-97.26B | ---- | -2.86%-47.82B | ---- | -10.73%-97.4B | ---- | 0.23%-46.48B | ---- |
| Operating expenses | -0.63%-48.11B | 0.14%-97.26B | -2.86%-47.82B | -10.73%-97.4B | 0.23%-46.48B | |||||
| Gross profit | -2.55%8.53B | 9.23%17.85B | 1.46%8.75B | 16.55%16.34B | 19.52%8.63B | |||||
| Administrative expenses | 10.00%-1.09B | ---- | -7.59%-2.82B | ---- | 3.90%-1.21B | ---- | -7.73%-2.62B | ---- | -13.45%-1.26B | ---- |
| Special items of operating profit | ---- | ---- | -64.26%231.36M | ---- | ---- | ---- | -58.96%647.34M | ---- | ---- | ---- |
| Operating profit | -1.36%7.44B | 6.21%15.26B | 2.38%7.54B | 9.14%14.36B | 9.55%7.37B | |||||
| Financing cost | 11.72%-1.3B | ---- | -0.56%-3.22B | ---- | 5.25%-1.47B | ---- | -7.12%-3.2B | ---- | -5.39%-1.55B | ---- |
| Share of profits of associates | 844.37%46.95M | ---- | -14.94%267.56M | ---- | -97.13%4.97M | ---- | -5.81%314.54M | ---- | -22.88%173.31M | ---- |
| Share of profit from joint venture company | 31.88%798.78M | 79.08%994.67M | 1.23%637.7M | 2.56%2.5B | 75.45%605.71M | -17.26%555.44M | 128.92%629.97M | --2.44B | 285.31%345.24M | -6.39%671.3M |
| Special items of earning before tax | 42.26%164.94M | ---- | ---- | ---- | 286.86%115.94M | ---- | ---- | ---- | --29.97M | ---- |
| Earning before tax | 5.21%7.15B | 6.90%12.94B | 6.83%6.8B | 12.29%12.1B | 14.32%6.36B | |||||
| Tax | -14.84%-1.64B | ---- | -19.73%-2.86B | ---- | -16.52%-1.43B | ---- | -3.52%-2.39B | ---- | -17.21%-1.23B | ---- |
| After-tax profit from continuing operations | 2.65%5.51B | 3.75%10.08B | 4.52%5.37B | 14.68%9.71B | 13.65%5.13B | |||||
| Earning after tax | 2.65%5.51B | 3.75%10.08B | 4.52%5.37B | 14.68%9.71B | 13.65%5.13B | |||||
| Minority profit | -28.93%135.75M | ---- | 41.32%344.98M | ---- | 37.29%191.02M | ---- | 12.62%244.12M | ---- | -11.47%139.14M | ---- |
| Special items of profit attributable to shareholders | -32.70%114.32M | ---- | 21.66%370.82M | ---- | 15.49%169.88M | ---- | 3.03%304.79M | ---- | 0.10%147.09M | ---- |
| Profit attributable to shareholders | 5.05%5.26B | 2.15%9.36B | 3.25%5.01B | 15.17%9.16B | 15.06%4.85B | |||||
| Basic earnings per share | 2.07%1.0143 | 2.20%1.86 | 3.24%0.9937 | 15.19%1.82 | 15.06%0.9625 | |||||
| Diluted earnings per share | 2.07%1.0143 | 2.20%1.86 | 3.24%0.9937 | 15.19%1.82 | 15.06%0.9625 | |||||
| Currency Unit | CNY | HKD | HKD | HKD | CNY | HKD | HKD | HKD | HKD | HKD |
| Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
| Audit Opinions | -- | -- | Unqualified Opinion | -- | -- | -- | Unqualified Opinion | -- | -- | -- |
| Auditor | -- | -- | Ernst & Young | -- | -- | -- | Ernst & Young | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.